<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title>sorafenib</title><link>http://www.unboundmedicine.com/medline/ebm/research/sorafenib</link><description>Unbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.</description><language>en-us</language><copyright>Unbound Medicine, Inc.</copyright><item><title>Synthesis and Antiproliferative Activitiy of Novel Diaryl Ureas Possessing a 4H-Pyrido[1,2-a]pyrimidin-4-one Group.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19927308/full_citation/Synthesis_and_Antiproliferative_Activitiy_of_Novel_Diaryl_Ureas_Possessing_a_4H_Pyrido[12_a]pyrimidin_4_one_Group_</link><description>Yao P, Zhai X, Liu D, et al. <br/><span class="title">Synthesis and Antiproliferative Activitiy of Novel Diaryl Ureas Possessing a 4H-Pyrido[1,2-a]pyrimidin-4-one Group. [JOURNAL ARTICLE]</span><br/><span class="source" title="Archiv der Pharmazie">Arch Pharm (Weinheim) 2009 Nov 19.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19927308/abstract/Synthesis_and_Antiproliferative_Activitiy_of_Novel_Diaryl_Ureas_Possessing_a_4H_Pyrido[12_a]pyrimidin_4_one_Group_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19927308/full_citation/Synthesis_and_Antiproliferative_Activitiy_of_Novel_Diaryl_Ureas_Possessing_a_4H_Pyrido[12_a]pyrimidin_4_one_Group_">Full Citation</a></description></item><item><title>Review article: management of hepatocellular carcinoma.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19925500/full_citation/Review_article:_management_of_hepatocellular_carcinoma_</link><description>Cabrera R, Nelson DR <br/><span class="title">Review article: management of hepatocellular carcinoma. [JOURNAL ARTICLE]</span><br/><span class="source" title="Alimentary pharmacology &amp; therapeutics">Aliment Pharmacol Ther 2009 Nov 19.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19925500/abstract/Review_article:_management_of_hepatocellular_carcinoma_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19925500/full_citation/Review_article:_management_of_hepatocellular_carcinoma_">Full Citation</a></description></item><item><title>Salvage therapy with sorafenib plus vinblastine and fluorouracil for metastatic renal cell carcinoma.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19925379/full_citation/Salvage_therapy_with_sorafenib_plus_vinblastine_and_fluorouracil_for_metastatic_renal_cell_carcinoma_</link><description>Tai CJ <br/><span class="title">Salvage therapy with sorafenib plus vinblastine and fluorouracil for metastatic renal cell carcinoma. [JOURNAL ARTICLE]</span><br/><span class="source" title="Acta oncologica (Stockholm, Sweden)">Acta Oncol 2009; 48(6):931-932.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19925379/full_citation/Salvage_therapy_with_sorafenib_plus_vinblastine_and_fluorouracil_for_metastatic_renal_cell_carcinoma_">Full Citation</a></description></item><item><title>Hand-Foot Syndrome (Hand-Foot Skin Reaction, Palmar-Plantar Erythrodysesthesia): Focus on Sorafenib and Sunitinib.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19923864/full_citation/Hand_Foot_Syndrome__Hand_Foot_Skin_Reaction_Palmar_Plantar_Erythrodysesthesia_:_Focus_on_Sorafenib_and_Sunitinib_</link><description>Lipworth AD, Robert C, Zhu AX <br/><span class="title">Hand-Foot Syndrome (Hand-Foot Skin Reaction, Palmar-Plantar Erythrodysesthesia): Focus on Sorafenib and Sunitinib. [JOURNAL ARTICLE]</span><br/><span class="source" title="Oncology">Oncology 2009 Nov 16; 77(5):257-271.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19923864/abstract/Hand_Foot_Syndrome__Hand_Foot_Skin_Reaction_Palmar_Plantar_Erythrodysesthesia_:_Focus_on_Sorafenib_and_Sunitinib_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19923864/full_citation/Hand_Foot_Syndrome__Hand_Foot_Skin_Reaction_Palmar_Plantar_Erythrodysesthesia_:_Focus_on_Sorafenib_and_Sunitinib_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19923864/Hand_Foot_Syndrome__Hand_Foot_Skin_Reaction_Palmar_Plantar_Erythrodysesthesia_:_Focus_on_Sorafenib_and_Sunitinib_">Find Related Articles</a> </description></item><item><title>Elevated International Normalized Ratio associated with concurrent use of sorafenib and warfarin.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19923313/full_citation/Elevated_International_Normalized_Ratio_associated_with_concurrent_use_of_sorafenib_and_warfarin_</link><description>Moretti LV, Montalvo RO <br/><span class="title">Elevated International Normalized Ratio associated with concurrent use of sorafenib and warfarin. [JOURNAL ARTICLE]</span><br/><span class="source" title="American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists">Am J Health Syst Pharm 2009 Dec 1; 66(23):2123-2125.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19923313/abstract/Elevated_International_Normalized_Ratio_associated_with_concurrent_use_of_sorafenib_and_warfarin_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19923313/full_citation/Elevated_International_Normalized_Ratio_associated_with_concurrent_use_of_sorafenib_and_warfarin_">Full Citation</a> | <a href="http://www.ajhp.org/cgi/pmidlookup%3fview=long%26amp;pmid=19923313">Publisher Full Text</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19923313/Elevated_International_Normalized_Ratio_associated_with_concurrent_use_of_sorafenib_and_warfarin_">Find Related Articles</a> </description></item><item><title>Plantar erythrodysesthesia with bullous otitis externa, toxicities from sorafenib: a case report.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19918567/full_citation/Plantar_erythrodysesthesia_with_bullous_otitis_externa_toxicities_from_sorafenib:_a_case_report_</link><description>Carter CA, Rajan A, Giaccone G <br/><span class="title">Plantar erythrodysesthesia with bullous otitis externa, toxicities from sorafenib: a case report. [Journal Article]</span><br/><span class="source" title="Cases journal">Cases J 2009.:6264.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19918567/abstract/Plantar_erythrodysesthesia_with_bullous_otitis_externa_toxicities_from_sorafenib:_a_case_report_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19918567/full_citation/Plantar_erythrodysesthesia_with_bullous_otitis_externa_toxicities_from_sorafenib:_a_case_report_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19918567/Plantar_erythrodysesthesia_with_bullous_otitis_externa_toxicities_from_sorafenib:_a_case_report_">Find Related Articles</a> </description></item><item><title>C-Raf inhibits MAPK activation and transformation by B-Raf(V600E).</title><link>http://www.unboundmedicine.com/medline/ebm/record/19917255/full_citation/C_Raf_inhibits_MAPK_activation_and_transformation_by_B_Raf_V600E__</link><description>Karreth FA, DeNicola GM, Winter SP, et al. <br/><span class="title">C-Raf inhibits MAPK activation and transformation by B-Raf(V600E). [Journal Article, Research Support, Non-U.S. Gov't]</span><br/><span class="source" title="Molecular cell">Mol Cell 2009 Nov 13; 36(3):477-86.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19917255/abstract/C_Raf_inhibits_MAPK_activation_and_transformation_by_B_Raf_V600E__">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19917255/full_citation/C_Raf_inhibits_MAPK_activation_and_transformation_by_B_Raf_V600E__">Full Citation</a> | <a href="http://linkinghub.elsevier.com/retrieve/pii/S1097-2765(09)00782-5">Publisher Full Text</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19917255/C_Raf_inhibits_MAPK_activation_and_transformation_by_B_Raf_V600E__">Find Related Articles</a> </description></item><item><title>Mechanisms of Myocyte Cytotoxicity Induced by the Multikinase Inhibitor Sorafenib.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19915982/full_citation/Mechanisms_of_Myocyte_Cytotoxicity_Induced_by_the_Multikinase_Inhibitor_Sorafenib_</link><description>Hasinoff BB, Patel D <br/><span class="title">Mechanisms of Myocyte Cytotoxicity Induced by the Multikinase Inhibitor Sorafenib. [JOURNAL ARTICLE]</span><br/><span class="source" title="Cardiovascular toxicology">Cardiovasc Toxicol 2009 Nov 14.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19915982/abstract/Mechanisms_of_Myocyte_Cytotoxicity_Induced_by_the_Multikinase_Inhibitor_Sorafenib_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19915982/full_citation/Mechanisms_of_Myocyte_Cytotoxicity_Induced_by_the_Multikinase_Inhibitor_Sorafenib_">Full Citation</a></description></item><item><title>Abnormalities of thyroid function in Japanese patients with metastatic renal cell carcinoma treated with sorafenib: A prospective evaluation.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19914105/full_citation/Abnormalities_of_thyroid_function_in_Japanese_patients_with_metastatic_renal_cell_carcinoma_treated_with_sorafenib:_A_prospective_evaluation_</link><description>Miyake H, Kurahashi T, Yamanaka K, et al. <br/><span class="title">Abnormalities of thyroid function in Japanese patients with metastatic renal cell carcinoma treated with sorafenib: A prospective evaluation. [JOURNAL ARTICLE]</span><br/><span class="source" title="Urologic oncology">Urol Oncol 2009 Nov 12.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19914105/abstract/Abnormalities_of_thyroid_function_in_Japanese_patients_with_metastatic_renal_cell_carcinoma_treated_with_sorafenib:_A_prospective_evaluation_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19914105/full_citation/Abnormalities_of_thyroid_function_in_Japanese_patients_with_metastatic_renal_cell_carcinoma_treated_with_sorafenib:_A_prospective_evaluation_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19914105/Abnormalities_of_thyroid_function_in_Japanese_patients_with_metastatic_renal_cell_carcinoma_treated_with_sorafenib:_A_prospective_evaluation_">Find Related Articles</a> </description></item><item><title>Synergistic interactions between sorafenib and bortezomib in hepatocellular carcinoma involve PP2A-dependent Akt inactivation.</title><link>http://www.unboundmedicine.com/medline/ebm/record/19913321/full_citation/Synergistic_interactions_between_sorafenib_and_bortezomib_in_hepatocellular_carcinoma_involve_PP2A_dependent_Akt_inactivation_</link><description>Chen KF, Yu HC, Liu TH, et al. <br/><span class="title">Synergistic interactions between sorafenib and bortezomib in hepatocellular carcinoma involve PP2A-dependent Akt inactivation. [JOURNAL ARTICLE]</span><br/><span class="source" title="Journal of hepatology">J Hepatol 2009 Oct 23.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/19913321/abstract/Synergistic_interactions_between_sorafenib_and_bortezomib_in_hepatocellular_carcinoma_involve_PP2A_dependent_Akt_inactivation_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/19913321/full_citation/Synergistic_interactions_between_sorafenib_and_bortezomib_in_hepatocellular_carcinoma_involve_PP2A_dependent_Akt_inactivation_">Full Citation</a> | <a rel="nofollow" href="http://www.unboundmedicine.com/medline/ebm/related/19913321/Synergistic_interactions_between_sorafenib_and_bortezomib_in_hepatocellular_carcinoma_involve_PP2A_dependent_Akt_inactivation_">Find Related Articles</a> </description></item></channel></rss>